CONSELHO FEDERAL DE MEDICINA (CFM) E CONSELHOS REGIONAIS (CRM)
CONTRATACOES PARA PALESTRAS E CONSULTORIAS
A PHASE 23 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BELIMUMAB ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH SYSTEMIC SCLEROSIS ASSOCIATE
GLAXOSMITHKLINE BRASIL LTDA.
Informação não registrada.